For instance, it is postulated that astrocytes within the hypoxic microenvironment release the cytokine CCL20 and upregulate HIF1α in an NF-κB signaling-dependent manner, thereby creating hypoxia adaptation for GBM [123]. The gene discussed is NFKB1; the disease is glioblastoma.